MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Genome-wide DNA methylation analysis reveals epigenetic perturbations in Parkinson disease.

J. Young, S. Sivasankaran, L. Wang, A. Ali, A. Mehta, D. Davis, K. Belle, D. Dykxhoorn, C. Petito, G. Beecham, E. Martin, D. Mash, W. Scott, J. Vance (Miami, FL, USA)

Meeting: 2017 International Congress

Abstract Number: 1059

Keywords: Parkinsonism

Session Information

Date: Wednesday, June 7, 2017

Session Title: Parkinson's Disease: Genetics

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective: Several environmental exposures are known to affect the risk for PD. Because DNA methylation is affected by environmental variables, we investigated whether brain region-specific DNA methylation patterns differ between PD cases and controls.

Background: Genetic variations have been associated with Parkinson disease (PD), but only explain part of the disease risk. Studies have shown that there are many environmental exposures that modify the risk of PD. As DNA methylation is one the known mechanisms through which environment can influence biological process, we investigated whether methylation differences exist between PD and controls. Because DNA methylation profiles vary between brain regions, we investigated areas of the brain relevant for PD. These included the dorsal motor nucleus of the vagus (DMV), the substantia nigra (SN) and the cingulate gyrus (CG).

Methods: We investigated the association of DNA methylation patterns with PD by performing a genome-wide screen of DNA methylation on the DMV, SN and CG in 12 autopsy-confirmed PD and 11 autopsy-confirmed controls. We used Illumina 450K beadchips to interrogate gene promoters and CpG islands.

Results: We found 9,621 CpG sites that were differentially methylated between PD and controls at false discovery rate (FDR) of <0.05 and absolute differential methylation (|ΔM|) of ≥ 1.5 fold in the DMV, with none and 1 CpG site differentially methylated in the SN and CG, respectively. The methylation status of neighbor CpG sites has been shown to be highly correlated, leading to the identification of differentially methylated regions (DMRs), which are less subject to identification artifacts than single CpG site methylation. We identified 1,775 DMRs in the DMV (FDR<0.05), including some in genes previously reported as associated to PD, like MAPT. A combined analysis of both methylation and RNA-seq data revealed 90 genes with significant DMRs that were also significantly differentially expressed. Pathway analysis of these genes showed significant enrichment for synaptic or neurotransmitter function (P value < 0.001).

Conclusions: Our data suggest that an epigenetic-load mechanism affecting genes involved in neurotransmission and synaptic pathways is a likely factor in neurodegenerative processes of PD.

To cite this abstract in AMA style:

J. Young, S. Sivasankaran, L. Wang, A. Ali, A. Mehta, D. Davis, K. Belle, D. Dykxhoorn, C. Petito, G. Beecham, E. Martin, D. Mash, W. Scott, J. Vance. Genome-wide DNA methylation analysis reveals epigenetic perturbations in Parkinson disease. [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/genome-wide-dna-methylation-analysis-reveals-epigenetic-perturbations-in-parkinson-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/genome-wide-dna-methylation-analysis-reveals-epigenetic-perturbations-in-parkinson-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley